HealthSouth Corporation (NYSE:HLS) Raised to “Buy” at Mizuho

Mizuho upgraded shares of HealthSouth Corporation (NYSE:HLS) from a neutral rating to a buy rating in a research report report published on Thursday, November 2nd, Marketbeat Ratings reports. They currently have $55.00 price target on the stock.

HLS has been the topic of a number of other reports. Stephens began coverage on HealthSouth Corporation in a research note on Thursday, August 31st. They issued an overweight rating and a $53.00 price objective on the stock. Zacks Investment Research upgraded HealthSouth Corporation from a sell rating to a hold rating in a research note on Wednesday, October 11th. Royal Bank Of Canada restated a buy rating and issued a $55.00 price objective on shares of HealthSouth Corporation in a research note on Wednesday, September 6th. KeyCorp restated a hold rating on shares of HealthSouth Corporation in a research note on Thursday, September 7th. Finally, ValuEngine upgraded HealthSouth Corporation from a hold rating to a buy rating in a research note on Friday, July 7th. Two analysts have rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. HealthSouth Corporation has a consensus rating of Hold and an average price target of $51.75.

Shares of HealthSouth Corporation (HLS) opened at $48.46 on Thursday. The company has a market capitalization of $4,680.00, a price-to-earnings ratio of 17.16, a PEG ratio of 1.76 and a beta of 0.52. HealthSouth Corporation has a 52 week low of $38.24 and a 52 week high of $49.99. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.34 and a current ratio of 1.34.

HealthSouth Corporation (NYSE:HLS) last released its earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. HealthSouth Corporation had a return on equity of 22.81% and a net margin of 6.69%. The company had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. During the same period in the previous year, the business posted $0.65 EPS. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. research analysts predict that HealthSouth Corporation will post 2.72 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This article was published by BBNS and is the property of of BBNS. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://baseballnewssource.com/markets/healthsouth-corporation-hls-upgraded-to-buy-at-mizuho/1752020.html.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Tuesday, January 2nd will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 2.06%. The ex-dividend date is Friday, December 29th. HealthSouth Corporation’s payout ratio is 36.50%.

In other HealthSouth Corporation news, Director Yvonne M. Curl acquired 1,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was bought at an average price of $45.95 per share, with a total value of $45,950.00. Following the completion of the acquisition, the director now owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by insiders.

Large investors have recently added to or reduced their stakes in the stock. Advisor Group Inc. lifted its position in HealthSouth Corporation by 33.8% in the 2nd quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after buying an additional 781 shares during the last quarter. Aviva PLC lifted its position in HealthSouth Corporation by 67.5% in the second quarter. Aviva PLC now owns 43,670 shares of the company’s stock valued at $2,133,000 after purchasing an additional 17,600 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its position in HealthSouth Corporation by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 671,304 shares of the company’s stock valued at $32,492,000 after purchasing an additional 34,035 shares during the last quarter. Mackay Shields LLC bought a new stake in HealthSouth Corporation in the second quarter valued at approximately $39,641,000. Finally, Prudential Financial Inc. lifted its position in HealthSouth Corporation by 137.1% in the second quarter. Prudential Financial Inc. now owns 434,679 shares of the company’s stock valued at $21,039,000 after purchasing an additional 251,372 shares during the last quarter. Institutional investors own 92.43% of the company’s stock.

HealthSouth Corporation Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.